Atai Life Sciences N V (ATAI)

12:08 PM

ATAI and Beckley Psytech Set to Merge in Strategic All-Share Dea - GuruFocus

12:08 PM

Jun 04, 2025

Regeneron makes obesity push; Atai, Alto ink brain drug deals - Yahoo Finance

Jun 04, 2025

Jun 03, 2025

ATAI Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Atai Life Sciences N.V. is Fair to Shareholders - Business Wire

Jun 03, 2025

Jun 03, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BPMC, STRM, ATAI, STR on Behalf of Shareholders - PR Newswire

Jun 03, 2025

Jun 03, 2025

H.C. Wainwright maintains buy rating on atai Life Sciences stock By Investing.com - Investing.com India

Jun 03, 2025

Jun 03, 2025

H.C. Wainwright maintains buy rating on atai Life Sciences stock - Investing.com

Jun 03, 2025

Jun 02, 2025

Atai Life Sciences Merges With Beckley Psytech In Major Shakeup - Finimize

Jun 02, 2025

Jun 02, 2025

atai Life Sciences and Beckley Psytech merging - Seeking Alpha

Jun 02, 2025

Jun 02, 2025

Atai Life Sciences, Beckley Psytech to Merge in All-Stock Transaction - marketscreener.com

Jun 02, 2025

Jun 02, 2025

Transcript : Atai Life Sciences N.V., Beckley Psytech LimitedM&A Call - marketscreener.com

Jun 02, 2025

Jun 02, 2025

Thiel-Backed Psychedelic Drugmaker Atai to Combine With Beckley - Bloomberg

Jun 02, 2025

Jun 02, 2025

ATAI and Beckley Psytech Plan Merger in Strategic All-Share Deal | ATAI Stock News - GuruFocus

Jun 02, 2025

Jun 02, 2025

atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies - Yahoo Finance

Jun 02, 2025

May 30, 2025

Beckley Psytech & atai Life Sciences to combine expertise in pivotal merger - Mugglehead Magazine

May 30, 2025

May 29, 2025

atai Life Sciences to Participate in Upcoming Investor Conferences - Yahoo

May 29, 2025

May 27, 2025

2 ‘Strong Buy’ Psychedelic Stocks To Scoop Up ASAP - Barchart.com

May 27, 2025

May 24, 2025

Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors - Benzinga

May 24, 2025

May 23, 2025

atai Life Sciences N.V. (ATAI) Is Up 18.71% in One Week: What You Should Know - Nasdaq

May 23, 2025

May 22, 2025

atai Life Sciences N.V. (ATAI) Just Flashed Golden Cross Signal: Do You Buy? - sharewise

May 22, 2025

May 22, 2025

Is atai Life Sciences (ATAI) Outperforming Other Medical Stocks This Year? - Yahoo Finance

May 22, 2025

May 21, 2025

atai Life Sciences holds annual general meeting - Investing.com Australia

May 21, 2025

May 21, 2025

atai Life Sciences holds annual general meeting By Investing.com - Investing.com India

May 21, 2025

May 21, 2025

ATAI Life Sciences Approves Key Governance Changes - TipRanks

May 21, 2025

May 21, 2025

Phase 2a data for BPL-003 ‘encouraging’ for Atai Life Sciences, says Jefferies - Yahoo Finance

May 21, 2025

May 21, 2025

ATAI Life Sciences Sees Significant Rise in Borrow Rate | ATAI S - GuruFocus

May 21, 2025

May 20, 2025

ATAI Stock Poised for Growth After Positive Phase 2a Data on BPL - GuruFocus

May 20, 2025

May 20, 2025

ATAI Stock Poised for Growth After Positive Phase 2a Data on BPL-003 | ATAI Stock News - GuruFocus

May 20, 2025

May 20, 2025

ATAI Life Sciences (ATAI) Shows Encouraging Mid-Stage Trial Resu - GuruFocus

May 20, 2025

May 20, 2025

atai Life Sciences reports positive data from mid-stage depression trial - Seeking Alpha

May 20, 2025

May 20, 2025

ATAI Reiterates a 'Buy' Rating with a Price Target of $10 | ATAI Stock News - GuruFocus

May 20, 2025

May 20, 2025

Atai Life Sciences Reports Positive Phase 2a Results for Treatment-Resistant Depression Drug - marketscreener.com

May 20, 2025

May 20, 2025

ATAI Life Sciences Reports Promising Findings from Depression Study | ATAI Stock News - GuruFocus

May 20, 2025

May 20, 2025

atai reports positive phase 2a results for depression treatment By Investing.com - Investing.com UK

May 20, 2025

May 20, 2025

atai Life Sciences Announces Positive Topline Data from Part 2 of Beckley Psytech’s Phase 2a Study of BPL-003 in Combination with SSRIs for Treatment-Resistant Depression - Yahoo Finance

May 20, 2025

May 20, 2025

Psychedelic stocks up after FDA chief’s comments (ATAI:NASDAQ) - Seeking Alpha

May 20, 2025

May 19, 2025

How Do Things Look For ATAI Life Sciences N.V (NASDAQ: ATAI) In The Short-Term? - Stocksregister

May 19, 2025

May 16, 2025

Despite Lacking Profits Atai Life Sciences (NASDAQ:ATAI) Seems To Be On Top Of Its Debt - simplywall.st

May 16, 2025

May 15, 2025

ATAI Explores Psychedelic Solutions for Veterans' Mental Health - GuruFocus

May 15, 2025

May 15, 2025

ATAI Explores Psychedelic Solutions for Veterans' Mental Health | ATAI Stock News - GuruFocus

May 15, 2025

May 15, 2025

Atai Life Sciences: Progress in Psychedelic Mental Health Treatments - TipRanks

May 15, 2025

May 14, 2025

Will Atai Get A New Lease Of Life? - RTTNews

May 14, 2025

May 14, 2025

Atai Life Sciences Reports First Quarter 2025 Financial Results - marketscreener.com

May 14, 2025

May 14, 2025

ATAI Reports Significant First Quarter Revenue Growth | ATAI Sto - GuruFocus

May 14, 2025

May 14, 2025

ATAI Sees Financial Boost with Cash Reserves Rise | ATAI Stock N - GuruFocus

May 14, 2025

May 14, 2025

ATAI Reports Significant First Quarter Revenue Growth | ATAI Stock News - GuruFocus

May 14, 2025

May 14, 2025

atai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate Updates - The Manila Times

May 14, 2025

May 13, 2025

Certain Restricted stock units of Atai Life Sciences N.V. are subject to a Lock-Up Agreement Ending on 14-MAY-2025. - marketscreener.com

May 13, 2025

May 13, 2025

Certain Options of Atai Life Sciences N.V. are subject to a Lock-Up Agreement Ending on 14-MAY-2025. - marketscreener.com

May 13, 2025

May 13, 2025

ATAI Begins Phase 2 Study for Social Anxiety Treatment | ATAI St - GuruFocus

May 13, 2025

May 13, 2025

Atai Life Sciences Announces First Patient Dosed In Phase 2 Study Of Emp-01 For The Treatment Of Social Anxiety Disorder - marketscreener.com

May 13, 2025

May 13, 2025

atai Life Sciences Announces First Patient Dosed in Phase 2 Study of EMP-01 for the Treatment of Social Anxiety Disorder - Yahoo

May 13, 2025